Asset Details
Do you wish to reserve the book?
Identification of altered salivary microRNAs in Cavalier King Charles Spaniels affected by mitral valve disease at different ACVIM stages
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Identification of altered salivary microRNAs in Cavalier King Charles Spaniels affected by mitral valve disease at different ACVIM stages
Do you wish to request the book?
Identification of altered salivary microRNAs in Cavalier King Charles Spaniels affected by mitral valve disease at different ACVIM stages
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Identification of altered salivary microRNAs in Cavalier King Charles Spaniels affected by mitral valve disease at different ACVIM stages
2026
Overview
Myxomatous mitral valve disease (MMVD) in Cavalier King Charles Spaniels (CKCSs) can be diagnosed at a young age. Early and sensitive biomarkers related to the disease are currently lacking. MicroRNAs (miRNAs) are involved in the onset and progression of canine MMVD. This study aimed to profile the salivary miRNAs associated with MMVD severity in CKCSs and to identify their target genes. This was a pilot prospective, cross-sectional study. Saliva was collected from twenty-five CKCSs belonging to the American College of Veterinary Internal Medicine (ACVIM) stages A (n. 6), B1 (n. 13), and B2 (n. 6), and salivary miRNAs’ expression was profiled by Next Generation Sequencing. miRNAs’ target genes were identified using bioinformatic tools. Results showed that 25 miRNAs were differentially expressed (DE) between ACVIM A and B1 dogs; 35 DE-miRNAs were modulated in ACVIM B2 compared to B1 CKCSs; 4 miRNAs were up-regulated in ACVIM stage B1 patients compared to both ACVIM stages A and B2. These findings confirm that salivary miRNAs can be successfully quantified in CKCSs and that their expression differs across MMVD severity groups. The DE-miRNAs were associated with signalling pathways related to cellular metabolism, survival, and early inflammatory remodeling. Given the exploratory and cross-sectional design, these miRNAs should be considered candidate, non-invasive indicators associated with disease severity rather than established biomarkers. Further longitudinal and validation studies are needed to assess their diagnostic potential.
Publisher
Nature Publishing Group UK,Nature Publishing Group,Nature Portfolio
